Incorporating Novel Muscarinic Agents for Schizophrenia Into Clinical Practice: Overcoming Clinical Inertia
Join us as we explore muscarinic antipsychotics in schizophrenia, with practical guidance on patient selection, titration, and managing adverse effects.
